NASDAQ:EXC • US30161N1019
ChartMill assigns a Buy % Consensus number of 68% to EXC. The Buy consensus is the weighted average rating of the current analysts ratings.
| Date | Firm | Action | Rating |
|---|---|---|---|
| 2026-02-13 | Mizuho | Maintains | Outperform -> Outperform |
| 2026-02-13 | ScotiaBank | Maintains | Sector Perform -> Sector Perform |
| 2026-02-13 | BMO Capital | Maintains | Outperform -> Outperform |
| 2026-02-13 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2026-01-27 | Jefferies | Maintains | Buy -> Buy |
| 2026-01-22 | Barclays | Maintains | Overweight -> Overweight |
| 2026-01-20 | Wells Fargo | Maintains | Overweight -> Overweight |
| 2025-12-17 | UBS | Maintains | Neutral -> Neutral |
| 2025-12-12 | JP Morgan | Maintains | Neutral -> Neutral |
| 2025-10-28 | Wells Fargo | Initiate | Overweight |
| 2025-10-22 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-10-15 | Keybanc | Maintains | Underweight -> Underweight |
| 2025-10-15 | Jefferies | Maintains | Buy -> Buy |
| 2025-10-14 | Barclays | Maintains | Overweight -> Overweight |
| 2025-10-10 | UBS | Maintains | Neutral -> Neutral |
| 2025-10-07 | Evercore ISI Group | Initiate | Outperform |
| 2025-09-25 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-07-16 | Keybanc | Maintains | Underweight -> Underweight |
| 2025-07-11 | UBS | Maintains | Neutral -> Neutral |
| 2025-06-02 | UBS | Maintains | Neutral -> Neutral |
| 2025-05-22 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-14 | Keybanc | Downgrade | Sector Weight -> Underweight |
| 2025-05-02 | Guggenheim | Maintains | Buy -> Buy |
| 2025-05-02 | Wells Fargo | Maintains | Equal-Weight -> Equal-Weight |
| 2025-05-02 | Evercore ISI Group | Maintains | In-Line -> In-Line |
| 2025-04-28 | BMO Capital | Maintains | Outperform -> Outperform |
| 2025-04-15 | Evercore ISI Group | Downgrade | Outperform -> In-Line |
| 2025-03-21 | UBS | Maintains | Neutral -> Neutral |
| 2025-03-20 | Morgan Stanley | Maintains | Equal-Weight -> Equal-Weight |
| 2025-02-25 | Barclays | Maintains | Overweight -> Overweight |
26 analysts have analysed EXC and the average price target is 49.42 USD. This implies a price increase of 4.61% is expected in the next year compared to the current price of 47.24.
The consensus rating for EXELON CORP (EXC) is 68.4615 / 100 . This indicates that analysts generally have a neutral outlook on the stock.